Danaher Co. (NYSE:DHR) Shares Acquired by Bogart Wealth LLC

Bogart Wealth LLC lifted its holdings in Danaher Co. (NYSE:DHR) by 11.2% in the fourth quarter, HoldingsChannel reports. The firm owned 37,548 shares of the conglomerate’s stock after buying an additional 3,783 shares during the quarter. Bogart Wealth LLC’s holdings in Danaher were worth $8,619,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Fort Pitt Capital Group LLC grew its position in shares of Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after buying an additional 7,421 shares in the last quarter. Good Life Advisors LLC acquired a new position in Danaher during the 3rd quarter worth approximately $217,000. ORG Partners LLC increased its position in shares of Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after purchasing an additional 2,559 shares during the last quarter. Harvest Portfolios Group Inc. raised its holdings in shares of Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after purchasing an additional 2,465 shares in the last quarter. Finally, Generate Investment Management Ltd purchased a new stake in shares of Danaher during the 4th quarter worth $8,044,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent analyst reports. KeyCorp boosted their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Barclays decreased their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Robert W. Baird cut their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Jefferies Financial Group decreased their target price on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Finally, Scotiabank started coverage on Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target on the stock. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Trading Up 0.7 %

NYSE:DHR opened at $203.56 on Friday. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a fifty day simple moving average of $230.49 and a 200-day simple moving average of $250.28. The company has a market capitalization of $147.03 billion, a PE ratio of 38.55, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm earned $2.09 EPS. On average, equities research analysts expect that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio is presently 20.45%.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.